Track topics on Twitter Track topics that are important to you
Breast imaging technologies are used for the early detection of breastrelated disorders. These technologies are mainly used to detect breast cancer at its initial stages. Various imaging modalities such as mammography, MRI, and ultrasound facilitate in the screening and staging of breast cancer by identifying characteristic masses or calcifications in the breast tissue.nnThe global breast imaging technologies market is expected to reach $4,502 million by 2022 from $2,544 million in 2015, growing at a CAGR of 8.4% during the forecast period. This market is expected to witness significant growth ahead owing to the increase in incidence of breast cancer globally and rise in initiatives by healthcare organizations to raise awareness about the early detection of breast cancer. The main drivers of the market include the need for technologically advanced products such automated whole breast ultrasound system AWBU for breast imaging and favorable reimbursement scenario. However, high cost of these imaging modalities and stringent regulatory approval processes hamper the market growth.nnThe breast imaging technologies market is segmented on the basis of product type and geography. Based on product type, it is bifurcated into ionizing breast imaging and nonionizing breast imaging technologies. Ionizing breast imaging technologies include analog mammography, fullfield digital mammography, 3D breast tomosynthesis, positron emission tomography/computed tomography PET/CT, molecular breast imaging/breastspecific gamma imaging MBI/BSGI, cone beam computed tomography CBCT, and positron emission mammography PEM. On the other hand, nonionizing breast imaging technologies are further divided into breast MRI, breast ultrasound, optical imaging, whole breast ultrasound, and breast thermography. The market is analyzed based on four regions, namely, North America, Europe, AsiaPacific, and LAMEA.nnProminent players adopted product development including product launches and approvals as their key developmental strategy for expanding their product portfolio. For instance, in June 2014, GE Healthcare received FDA approval of Invenia ABUS, which is an automated breast ultrasound system used for breast cancer detection. This system helps in detecting breast cancer in women with dense tissue when used as an adjunct with a mammogram.nnKey benefitsnnnnThis report provides an extensive analysis of the current and emerging market trends and dynamics from 2014 to 2022 in the global breast imaging technologies market.nnnbsp;Comprehensive analysis of all geographic regions is provided to determine the prevailing opportunities across the geographies and predict the competitive environment.nnComprehensive analysis of factors that drive and restrict the market growth is provided.nnRegion and countrywise breast imaging market conditions are comprehensively analyzed.nnnKey market segmentsnnBy Product TypennnnIonizing Breast Imaging TechnologiesnnnnnnAnalog MammographynnnFullField Digital Mammography FFDMnnn3D Breast TomosynthesisnnnPositron Emission Tomography/Computed Tomography Pet/CTnnnMolecular Breast Imaging/BreastSpecific Gamma Imaging MBI/BSGInnnCone Beam Computed Tomography CBCTnnnPositron Emission Mammography PEMnnnnnnNonIonizing Breast Imaging TechnologiesnnnnnBreast MRInnnBreast UltrasoundnnnOptical ImagingnnnAutomated Whole Breast Ultrasound AWBUnnnBreast ThermographynnnnnnnBy GeographynnnnNorth AmericannnnnnU.S.nnnCanadannnMexiconnnnnnEuropennnnnGermanynnnFrancennnUKnnnItalynnnSpainnnnRest of EuropennnnnnAsiaPacificnnnnnJapannnnChinannnIndiannnRest of AsiaPacificnnnnnnLAMEAnnnnnLatin AmericannnMiddle EastnnnAfricannnnnnnThe key players profiled in this report are as follows:nnnnDilon Technologies, Inc.nnFUJIFILM Holdings CorporationnnGamma Medica, Inc.nnGeneral Electric CompanynnHologic, Inc.nnKoning CorporationnnKoninklijke Philips N.V.nnSiemens AGnnSonocineacute;, Inc.nnToshiba corporationnnnOther players operating in the breast imaging technologies not elaborated in the report market include:nnnnAurora Imaging Technology, Inc.nnCarestream HealthnnDelphinus Medical Technologies, Inc.nnMicrima LimitednnTualatin Imaging, P.C.n
Original Article: Breast Imaging Technologies Market by Product [Ionizing Breast Imaging Technologies Analog Mammography, FullField Digital Mammography FFDM, 3D Breast Tomosynthesis Positron Emission Tomography/Computed Tomography PET/CT, Molecular Breast Imaging/BreastSpeNEXT ARTICLE
Track and monitor developments in breast cancer research and commercial development. Follow the tabs above to read the latest global news, research, clinical trials on breast cancer and follow companies active in the development of breast cancer tr...
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...
Radiology is the branch of medicine that studies imaging of the body; X-ray (basic, angiography, barium swallows), ultrasound, MRI, CT and PET. These imaging techniques can be used to diagnose, but also to treat a range of conditions, by allowing visuali...